Insider Trading & Ownership - Lawton Alison Frances

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lawton Alison Frances

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-10
Option Award
2024-06-11
4:12 pm
N/A
N/A
X4 Pharmaceuticals IncXFORLawton Alison Frances
Director
45,000$096,667
(Direct)
View
2024-05-23
Option Award
2024-05-28
7:58 pm
N/A
2034-05-22
Dianthus Therapeutics Inc.DNTHLawton Alison Frances
Director
11,000$011,000
(Direct)
View
2023-09-11
Option Award
2023-09-13
9:17 pm
N/A
2033-09-10
Dianthus Therapeutics Inc.DNTHLawton Alison Frances
Director
6,500$06,500
(Direct)
View
2023-06-22
Option Award
2023-06-30
4:30 pm
N/A
2033-06-22
Aeglea BioTherapeutics Inc.AGLELawton Alison Frances
Director
1,950,000$01,950,000
(Direct)
View
2023-06-13
Option Award
2023-06-14
4:51 pm
N/A
N/A
X4 Pharmaceuticals IncXFORLawton Alison Frances
Director
45,000$051,667
(Direct)
View
2022-06-28
Option Award
2022-06-30
6:36 pm
N/A
2032-06-27
Magenta Therapeutics Inc.MGTALawton Alison Frances
Director
20,000$020,000
(Direct)
View
2022-06-06
Option Award
2022-06-27
4:17 pm
N/A
N/A
X4 Pharmaceuticals IncXFORLawton Alison Frances
Director
6,667$06,667
(Direct)
View
2022-06-07
Option Award
2022-06-10
06:04 am
N/A
2032-06-06
Aeglea BioTherapeutics Inc.AGLELawton Alison Frances
Director
43,000$043,000
(Direct)
View
2021-06-08
Option Award
2021-06-09
5:24 pm
N/A
2031-06-07
Aeglea BioTherapeutics Inc.AGLELawton Alison Frances
Director
40,000$040,000
(Direct)
View
2021-06-01
Option Award
2021-06-03
6:36 pm
N/A
2031-05-31
Magenta Therapeutics Inc.MGTALawton Alison Frances
Director
18,188$018,188
(Direct)
View
2021-06-02
Option Award
2021-06-02
5:02 pm
N/A
2031-06-02
X4 Pharmaceuticals IncXFORLawton Alison Frances
Director
6,000$9.56,000
(Direct)
View
2020-12-22
Option Award
2020-12-23
7:13 pm
N/A
2030-12-21
Magenta Therapeutics Inc.MGTALawton Alison Frances
Director
36,377$036,377
(Direct)
View

Ownership
2020-12-23
7:09 pm
N/A
2027-09-26
Magenta Therapeutics Inc.MGTALawton Alison Frances
Director
0$052,244
(Direct)
View
2020-12-15
Option Award
2020-12-17
4:33 pm
N/A
2030-12-14
Aeglea BioTherapeutics Inc.AGLELawton Alison Frances
Director
47,200$047,200
(Direct)
View
2020-10-05
Option Award
2020-10-06
07:43 am
N/A
2030-10-04
X4 Pharmaceuticals IncXFORLawton Alison Frances
Director
6,854$06,854
(Direct)
View

Ownership
2020-10-06
07:39 am
N/A
N/A
X4 Pharmaceuticals IncXFORLawton Alison Frances
Director
0$010,134
(Direct)
View
2020-04-15
Option Award
2020-04-17
08:00 am
N/A
2030-04-14
Kaleido Biosciences Inc.KLDOLawton Alison Frances
See Remarks
118,500$0118,500
(Direct)
View
2020-02-28
Option Award
2020-03-03
9:07 pm
N/A
N/A
Kaleido Biosciences Inc.KLDOLawton Alison Frances
See Remarks
46,325$046,325
(Direct)
View
2019-11-15
Option Award
2019-11-18
4:05 pm
N/A
2029-11-14
Kaleido Biosciences Inc.KLDOLawton Alison Frances
See Remarks
150,000$0150,000
(Direct)
View